research Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
This case report describes a 50-year-old woman with palmoplantar psoriasis who developed alopecia areata after starting tildrakizumab, suggesting a possible paradoxical reaction related to the medication.


